Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liposomal Doxorubicin and IL-12 in AIDS-Associated Kaposi's Sarcoma
NCT00020449Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Jan 2001
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 2 trial of recombinant interleukin-12 in Kaposi sarcoma (KS), sponsored by National Cancer Institute. Started Jan 2001; status: completed.
02
Drugs
recombinant interleukin-12
03
Conditions
Kaposi sarcoma (KS)
Beyond the preview
Go deeper on NCT00020449.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00020449.